Dabigatran Etexilate Towa Pharmaceutical

Dabigatran Etexilate is an oral anticoagulant used to prevent blood clots. Manufactured by Towa Pharmaceutical Europe S.L., it helps manage conditions like atrial fibrillation and deep vein thrombosis.

Dabigatran Etexilate is primarily used to reduce the risk of blood clots forming in the body. It is often prescribed for conditions such as atrial fibrillation, where irregular heart rhythms can lead to clot formation. Additionally, it may be used to prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) in certain patients. Understanding what is Dabigatran Etexilate used for involves recognizing its role in managing and preventing clot-related issues.

Common effects of Dabigatran Etexilate may include minor bleeding, such as nosebleeds or bruising. Some users might experience stomach pain, heartburn, or indigestion. It's important to monitor for signs of unusual bleeding, as this could indicate a need for medical attention.

Dabigatran Etexilate should be handled with care, especially in patients with a history of bleeding disorders or kidney problems. It is crucial to follow the prescribed dosage and consult a healthcare provider before starting or stopping the medication. Always store the medication as directed and keep it out of reach of children.

Dabigatran Etexilate may interact with other medications, including certain anticoagulants, antiplatelet drugs, and nonsteroidal anti-inflammatory drugs (NSAIDs). Alcohol consumption should be moderated, as it can increase the risk of bleeding. Always inform your healthcare provider about all medications and supplements you are taking.